| Trial Identifier: | D7220C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04973449 |
| Start Date: | June 2021 |
| Primary Completion Date: | February 2022 |
| Study Completion Date: | August 2022 |
| Condition: | COVID-19 Immunisation |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Country | Location |
|---|---|
| BR | Brasilia, BR, 70200-730 |
| BR | Curitiba, BR, 80810-050 |
| BR | Natal, BR, 59025-050 |
| BR | Natal, BR, 59020-035 |
| BR | Porto Alegre, BR, 90035-903 |
| BR | Salvador, BR, 40110-060 |
| BR | São Paulo, BR, 04037-002 |
| GB | Birmingham, GB, B15 2TH |
| GB | Bournemouth, GB, BH7 7DW |
| GB | Bristol, GB, BS105NB |
| GB | Bristol, GB, BS2 8BJ |
| GB | Dundee, GB, DD1 9SY |
| GB | Edinburgh, GB, EH16 4SA |
| GB | Harrow, GB, HA1 3UJ |
| GB | Hull, GB, HU3 2KZ |
| GB | London, GB, NW1 2BH |
| GB | London, GB, E2 0HL |
| GB | London, GB, SE1 9RT |
| GB | London, GB, SE5 9NU |
| GB | Manchester, GB, M8 5RB |
| GB | Newcastle-upon-Tyne, GB, NE1 4LP |
| GB | Nottingham, GB, NG7 2QW |
| GB | Oxford, GB, OX3 7EJ |
| GB | Plymouth, GB, PL6 8DH |
| GB | Portsmouth, GB, PO1 3HN |
| GB | Sheffield, GB, S5 7AU |
| GB | Truro, GB, TR1 3LJ |
| PL | Kraków, PL, 30-348 |
| PL | Lublin, PL, 20-362 |
| PL | Oświęcim, PL, 32-600 |
| PL | Puławy, PL, 24-100 |
| PL | Skórzewo, PL, 60-185 |
| PL | Trzebnica, PL, 55-100 |
| PL | Zamosc, PL, 22-400 |
| ZA | Bloemfontein, ZA, 9301 |
| ZA | Cape Town, ZA, 7500 |
| ZA | Johannesburg, ZA, 1818 |
| ZA | Johannesburg, ZA, 2092 |
| ZA | Johannesburg, ZA, 2013 |
| ZA | Somerset West, ZA, 7130 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company